WEBINAR

20 million lost workdays:
Why Genentech is transforming the disability leave experience

Thursday, June 24, 2021
10:00AM PT / 1:00PM ET

Employees with the greatest mental health needs often find themselves navigating a complex disability system. Streamlining their mental health leave and recovery time leads to an overall more productive workforce.

What You’ll Learn

Employees with a severe mental health diagnosis are five times more likely to go on disability leave than their peers. The majority of these employees have difficulty quickly accessing a leave evaluation, further delaying their recovery time and contributing to meaningful loss of productivity for the company.

Join Lyra Health’s Medical Clinical Director of Psychiatry, Smita Das, MD, PhD, MPH, and Deborah Olson, Genentech’s Lead Strategist for Well-Being, for a discussion about why it’s crucial for employers to provide streamlined access to disability leave requests as well as high-quality care with Lyra’s new Clinical Leave Evaluation program.

In this webinar, you'll learn:

  • Why the process of obtaining a disability leave evaluation today is broken and why key players are not incentivized to help
  • Why Genentech wanted to offer a better employee experience and help provide fast access to care for members who are suffering from severe mental health needs
  • Lyra’s new Clinical Leave Evaluation program, including how members receive the care they need during their leave and build a transition plan to reintegrate back to work

Featured Speakers

Speaker One

Job Title, Company Name

Speaker Two

Job Title, Company Name

Speaker Three

Job Title, Company Name

Featured Speakers

Deborah Olson

Lead Strategist, Well-Being, Genentech

Smita Das, MD, PhD, MPH

Medical Director, Psychiatry, Lyra Health

Featured Speakers

Speaker One

Job Title, Company Name

About the Panel

Deborah Olson

Deborah Olson, Well-being, Lead Strategist at Genentech, a Roche Company, is an ability management strategist with a record of achievement designing and implementing mental wellness programs. She leads the Occupational and Non-Occupational Leave and Disability programs and the Mental Wellness program across Genentech and Roche in the U.S., supporting over 24,000 employees. Prior to joining Genentech, she founded a consulting firm where she supported teams at Kaiser Permanente and Lucile Packard Children’s Hospital at Stanford.

Smita Das, MD, PhD, MPH

Dr. Das is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine and has over 20 years of research experience in healthcare quality and addiction. She studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. Regionally, she has been a leader in the Northern California Psychiatric Society since 2012 and is now Immediate Past President of the American Psychiatric Association (APA) District Branch. Nationally, she serves on the Council on Addictions at the American Psychiatric Association, has presented to the US Congress and is an invited speaker at conferences. Prior to her position as Medical Director of Psychiatry at Lyra Health, she was Director of Addiction Treatment Services at the Palo Alto VA System. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Assistant Professor.